Market Size of Transfection Technologies Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 9.10 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Transfection Technologies Market Analysis
The market for transfection technologies is expected to grow at a CAGR of about 9.1% over the next few years.
The COVID-19 pandemic had a significant impact on the market studied. There had been increasing research on coronavirus and its spread during the pandemic. Transfection, the process that enables the delivery of nucleic acids into cells to overexpress a protein of interest and/or inhibit gene expression, contributed significantly to the development of novel strategies to cope with COVID-19. Companies such as Polyplus supported COVID-19 research by providing innovative transfection reagents for gentle yet efficient delivery into cells. Owing to the movements of such companies, there was a high utilization of transfection technologies, which impacted the market positively. However, currently, the market is in its pre-pandemic state and is expected to witness healthy growth in the coming years.
The market is growing because of things like the rise in chronic diseases and the increase in research and development in the field of cell-based therapies.
According to the Centers for Disease Control and Prevention's March 2022 publication, six out of every ten adults in the United States have a chronic disease, and four out of every ten adults have two or more chronic diseases. Chronic diseases, such as cancer, chronic lung diseases, kidney diseases, arthritis, and many more, are the leading causes of death and disability and the leading drivers of the nation's USD 4.1 trillion in annual healthcare costs. With the increasing burden of chronic diseases across the globe, there is a rising need for better therapeutics, for which various technologies have been developed. Transfection is one of the technologies that is being used largely to cope with chronic diseases. Since chronic diseases are so common, it is thought that the use of transfection technology will help the market grow in the coming years.
According to the American Cancer Society, the number of new cancer cases in the United States in 2021 is expected to be 1.9 million, with 608,570 cancer deaths.Since there are more and more people with chronic diseases like cancer, there will be more research into treatments for these diseases, which is thought to help the market grow.
But in the coming years, the growth of the market is likely to be slowed by the high cost of transfection technology instruments.
Transfection Technologies Industry Segmentation
As per the scope of the report, transfection is an analytical method to study the function of genes and gene products in the cells. Transfection technology is used to introduce nucleic acids like RNA or DNA into cells. It regulates gene therapy, protein metabolism, and cancer cell mutation by affecting nuclear genes.The market is segmented by method (reagent-based method, instrument-based method, and others), application (biomedical research, therapeutic delivery, protein production), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD million for the above segments.
| By Method | |
| Reagent-based Method | |
| Instrument-based Method | |
| Other Methods |
| By Application | |
| Biomedical Research | |
| Therapeutic Delivery | |
| Protein Production |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Transfection Technologies Market Size Summary
The transfection technologies market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and advancements in cell-based therapies. The market experienced a positive impact during the COVID-19 pandemic, as transfection technologies played a crucial role in developing strategies to combat the virus. Companies like Polyplus contributed by providing innovative transfection reagents, which enhanced the delivery of nucleic acids into cells. This heightened utilization of transfection technologies has set the stage for continued expansion. The market is now returning to its pre-pandemic trajectory, with expectations of robust growth fueled by the rising demand for effective therapeutics to address chronic conditions such as cancer and other prevalent diseases.
The reagent-based transfection technology segment is witnessing significant growth due to its cost-effectiveness and simplicity. Instrument-based methods, including electroporation and microinjection, also contribute to market expansion by offering accuracy and efficiency. New product launches, such as those by Polyplus and Mirus Bio, are further propelling this segment's growth, particularly in viral vector production for gene therapy. North America, especially the United States and Canada, is a key region for market growth, driven by the high incidence of chronic diseases and increased funding for gene therapy research. The competitive landscape includes major players like Lonza Group and Thermo Fisher Scientific, who offer a range of transfection solutions to pharmaceutical, biotechnology, and research organizations.
Transfection Technologies Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Incidences of Chronic Diseases
-
1.2.2 Increase in Research & Development in the Field of Cell Based Therapies
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Transfection Technology Instruments
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Method
-
2.1.1 Reagent-based Method
-
2.1.2 Instrument-based Method
-
2.1.3 Other Methods
-
-
2.2 By Application
-
2.2.1 Biomedical Research
-
2.2.2 Therapeutic Delivery
-
2.2.3 Protein Production
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Transfection Technologies Market Size FAQs
What is the current Transfection Technologies Market size?
The Transfection Technologies Market is projected to register a CAGR of 9.10% during the forecast period (2024-2029)
Who are the key players in Transfection Technologies Market?
Lonza Group , Bio-Rad Laboratories, Inc. , Promega Corporation , Thermo Fisher Scientific and Qiagen are the major companies operating in the Transfection Technologies Market.
